A massive clinical trial for coronavirus infection treatment began on Tuesday in the New York state where a half of the U.S. coronavirus cases are located and the infection curve is actually increasing.
The state acquired 70,000 doses of hydroxychloroquine, 10,000 doses of zithromax and 750,000 doses of chloroquine in the last few days. "We hope for optimistic results," New York’s Gov. Andrew Cuomo said. "The president and the FDA accelerated that drug coming to New York so the hospitals will start using that drug today." In the United States there are over 51,000 cases of the novel coronavirus. "New York is definitely a hot spot, there’s no question about it," President Donald Trump said Tuesday evening. A vaccine to treat COVID-19 is estimated to be at least a year away. However, there are some interesting considerations abot the use of hydroxychloroquine.
"Some health officials point to Africa, which has a very low infection rate and there's a theory that because they're taking these anti-malaria drugs in Africa, it may actually be one of the reasons why the infection rate is low in Africa. We don't know, but let's find out and let's find out quickly," Gov. Cuomo explained.